Sandwich, United Kingdom

James E Mills

This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2012.


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: James E Mills: Innovator in Pyrrolidine Compounds

Introduction

James E Mills is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of medicinal chemistry, particularly through his work on pyrrolidine compounds. His innovative approach has led to advancements in treatments for various medical conditions.

Latest Patents

James E Mills holds a patent for pyrrolidines, which relates to a class of pyrrolidine compounds of formula (I) and their pharmaceutically acceptable derivatives. This invention focuses on their use in medicine, compositions containing them, and processes for their preparation. The compounds are particularly useful for treating EP2-mediated conditions, such as endometriosis, uterine fibroids, menorrhagia, adenomyosis, and chronic pelvic pain syndrome.

Career Highlights

James E Mills is currently associated with Pfizer Corporation, a leading pharmaceutical company. His work at Pfizer has allowed him to contribute to the development of important medical treatments. His expertise in medicinal chemistry has been instrumental in advancing the company's research initiatives.

Collaborations

James has collaborated with several talented individuals, including Kevin Neil Dack and Sarah Elizabeth Skerratt. These collaborations have fostered a productive environment for innovation and research within the pharmaceutical sector.

Conclusion

James E Mills is a distinguished inventor whose work on pyrrolidine compounds has the potential to significantly impact medical treatments. His contributions to Pfizer Corporation and collaborations with fellow researchers highlight his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…